2023年美国心脏协会(AHA)发布了儿童心肌病治疗策略的科学声明,重点介绍扩张型和肥厚型心肌病的治疗策略,解决了目前缺乏儿童特有的心肌病的治疗方案问题,给出了基于AHA观点的方案 文章旨在通过解读该科学声明,为国内同行针对心肌病患儿制订治疗方案时提供基于AHA观点的决策依据.
In 2023,the American Heart Association(AHA)issued a scientific statement on the treatment strategies for child cardiomyopathy,focusing on dilated and hypertrophic cardiomyopathies,which addresses the lack of treatment options for children-specific cardiomyopathies and provides options based on the AHA perspective.The purpose of this paper is to interpret this scientific statement in order to provide an AHA-based decision-making evidence for domestic colleagues to develop treatment programs for children with cardiomyopathies.
李雅;朱丽琴;何玮梅;赵仕国;张晨美
浙江大学医学院附属儿童医院 国家儿童健康与疾病临床医学研究中心,浙江杭州 310052
临床医学
心肌病;儿童;美国心脏协会;科学声明;专家共识;指南
cardiomyopathy;child;American Heart Association;scientific statement;expert consensus;guidelines
《中国实用儿科杂志》 2024 (003)
168-174 / 7
国家重点研发计划(2021YFC2701800;2021YFC2701801)
10.19538/j.ek2024030602
评论